Abstract:Crystalline materials are crucial to the function of living organisms, in the shells of molluscs, the matrix of bone, the teeth of sea urchins, and the exoskeletons of coccoliths. However, pathological biomineralization can be an undesirable crystallization process associated with human diseases. The crystal growth of biogenic, natural and synthetic materials may be regulated by the action of modifiers, most commonly inhibitors, which range from small ions and molecules to large macromolecules. Inhibitors adsorb on crystal surfaces and impede the addition of solute, thereby reducing the rate of growth. Complex inhibitor-crystal interactions in biomineralization are often not well elucidated. Here we show that two molecular inhibitors of calcium oxalate monohydrate crystallization--citrate and hydroxycitrate--exhibit a mechanism that differs from classical theory in that inhibitor adsorption on crystal surfaces induces dissolution of the crystal under specific conditions rather than a reduced rate of crystal growth. This phenomenon occurs even in supersaturated solutions where inhibitor concentration is three orders of magnitude less than that of the solute. The results of bulk crystallization, in situ atomic force microscopy, and density functional theory studies are qualitatively consistent with a hypothesis that inhibitor-crystal interactions impart localized strain to the crystal lattice and that oxalate and calcium ions are released into solution to alleviate this strain. Calcium oxalate monohydrate is the principal component of human kidney stones and citrate is an often-used therapy, but hydroxycitrate is not. For hydroxycitrate to function as a kidney stone treatment, it must be excreted in urine. We report that hydroxycitrate ingested by non-stone-forming humans at an often-recommended dose leads to substantial urinary excretion. In vitro assays using human urine reveal that the molecular modifier hydroxycitrate is as effective an inhibitor of nucleation of calcium oxalate monohydrate nucleation as is citrate. Our findings support exploration of the clinical potential of hydroxycitrate as an alternative treatment to citrate for kidney stones.

Trace metal-citric acid complexes as inhibitors of calcification and crystal growth. II. Effects of Fe(III), Cr(III) and Al(III) complexes on calcium oxalate crystal growth

Trace metal-citric acid complexes as inhibitors of calcification and crystal growth. I. Effects of Fe(III), Cr(III) and Al(III) complexes on calcium phosphate crystal growth

Effect of Trisodium Citrate on Electrolytic Deposition of Hydroxyapatite Coatings

Phosphate recovery through struvite-family crystals precipitated in the presence of citric acid: mineralogical phase and morphology evaluation

Molecular modifiers reveal a mechanism of pathological crystal growth inhibition

Modulation of Mixed Potassium Carboxylates on Crystallization of Calcium Oxalate Crystals in Gel System

Effects of aluminum(III), chromium(III), and iron(III) on the rate of dissolution of calcium hydroxyapatite crystals in the absence and presence of the chelating agent desferrioxamine

Tartronic Acid As a Potential Inhibitor of Pathological Calcium Oxalate Crystallization

Inhibition of calcium oxalate monohydrate crystallization by the combination of citrate and osteopontin

Specificity of growth inhibitors and their cooperative effects in calcium oxalate monohydrate crystallization

Influences of Citric Acid on the Metastability of Α-Calcium Sulfate Hemihydrate in CaCl2 Solution

Aluminum citrate inhibits cytotoxicity and aggregation of oxalate crystals

Stabilizing Amorphous Calcium Phosphate Phase by Citrate Adsorption

Chemical and electrochemical study of the inhibition of calcium carbonate precipitation using citric acid and sodium citrate

Comparison of the Inhibitory Mechanisms of Diethyl Citrate, Sodium Citrate, and Phosphonoformic Acid on Calcification Induced by High Inorganic Phosphate Contents in Mouse Aortic Smooth Muscle Cells

Influence of Ionic Additives on Triclinic Calcium Pyrophosphate Dihydrate Precipitation

Reappraisal of the quantity and nature of renal calcifications and mineral metabolism in the magnesium-deficient rat. Effects of treatment with potassium citrate or the combination magnesium citrate and potassium citrate

Effect of Potassium Citrate on Calcium Phosphate Stones in a Model of Hypercalciuria

Effect of Alkaline Precipitation on Cr Species of Cr(III)-bearing Complexes Typically Used in the Tannery Industry.

Citrate Controls Fe(II)-Catalyzed Transformation of Ferrihydrite by Complexation of the Labile Fe(III) Intermediate.

Effect of Iron Ions on the Crystal Growth Kinetics and Microstructure of Calcium Carbonate